Literature DB >> 11461077

Mutation analysis of the p73 gene in nonastrocytic brain tumours.

M E Alonso1, M J Bello, P Gonzalez-Gomez, J Lomas, D Arjona, J M de Campos, M E Kusak, J L Sarasa, A Isla, J A Rey.   

Abstract

Loss of heterozygosity (LOH) involving the distal chromosome 1 p36 region occurs frequently in nonastrocytic brain tumours, but the tumour suppressor gene targeted by this deletion is unknown. p73 is a novel gene that has high sequence homology and similar gene structure to the p53 gene; it has been mapped to 1 p36, and may thus represent a candidate for this tumour suppressor gene. To determine whether p73 is involved in nonastrocytic brain tumour development, we analysed 65 tumour samples including 26 oligodendrogliomas, 4 ependymomas, 5 medulloblastomas, 10 meningiomas, 2 meningeal haemangiopericytomas, 2 neurofibrosarcomas, 3 primary lymphomas, 8 schwannomas and 5 metastatic tumours to the brain, for p73 alterations. Characterization of allelic loss at 1 p36-p35 showed LOH in about 50% of cases, primarily involving oligodendroglial tumours (22 of 26 cases analysed; 85%) and meningiomas (4 of 10; 40%). PCR-SSCP and direct DNA sequencing of exons 2 to 14 of p73 revealed a missense mutation in one primary lymphoma: a G-to-A transition, with Glu291Lys change. 8 additional cases displayed no tumour-specific alterations, as 3 distinct polymorphic changes were identified: a double polymorphic change of exon 5 was found in one ependymoma and both samples derived from an oligodendroglioma, as follows: a G-to-A transition with no change in Pro 146, and a C-to-T variation with no change in Asn 204: a delG at exon 3/+12 position was identified in 4 samples corresponding to 2 oligodendrogliomas, 1 ependymoma and 1 meningioma, and a C-to-T change at exon 2/+10 position was present in a metastatic tumour. Although both LOH at 1 p36 and p73 sequence changes were evidenced in 4 cases, it is difficult to establish a causal role of the p73 variations and nonastrocytic brain tumours development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461077      PMCID: PMC2364057          DOI: 10.1054/bjoc.2001.1855

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas.

Authors:  M Herranz; M Urioste; J Santos; J B Martinez-Delgado; C Rivas; J Benitez; J Fernández-Piqueras
Journal:  Leukemia       Date:  2000-07       Impact factor: 11.528

2.  The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3.

Authors:  T Tsujimoto; S Mochizuchi; Y Iwadate; H Namba; M Nagai; T Kawamoto; M Sunahara; A Yamaura; A Nakagawara; S Sakiyama; M Tagawa
Journal:  Anticancer Res       Date:  2000 Jul-Aug       Impact factor: 2.480

Review 3.  Structure, function and regulation of p63 and p73.

Authors:  M Levrero; V De Laurenzi; A Costanzo; J Gong; G Melino; J Y Wang
Journal:  Cell Death Differ       Date:  1999-12       Impact factor: 15.828

4.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.

Authors:  A Yang; N Walker; R Bronson; M Kaghad; M Oosterwegel; J Bonnin; C Vagner; H Bonnet; P Dikkes; A Sharpe; F McKeon; D Caput
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

5.  Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.

Authors:  C Y Peng; S L Tsai; C T Yeh; S P Hung; M F Chen; T C Chen; C M Chu; Y F Liaw
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

6.  High-resolution analysis of chromosome arm 1p alterations in meningioma.

Authors:  M J Bello; J M de Campos; J Vaquero; M E Kusak; J L Sarasa; J A Rey
Journal:  Cancer Genet Cytogenet       Date:  2000-07-01

7.  Differential expression and allelotyping of the p73 gene in neuroblastoma.

Authors:  W Liu; M Mai; A Yokomizo; C Qian; D J Tindall; D I Smith; S N Thibodeau
Journal:  Int J Oncol       Date:  2000-01       Impact factor: 5.650

8.  Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors.

Authors:  K Husemann; M Wolter; R Büschges; J Boström; M Sabel; G Reifenberger
Journal:  J Neuropathol Exp Neurol       Date:  1999-10       Impact factor: 3.685

9.  Mutation analysis of P73 and TP53 in Merkel cell carcinoma.

Authors:  M Van Gele; M Kaghad; J H Leonard; N Van Roy; J M Naeyaert; M L Geerts; S Van Belle; V Cocquyt; J Bridge; R Sciot; C De Wolf-Peeters; A De Paepe; D Caput; F Speleman
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

Review 10.  The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

Authors:  M Levrero; V De Laurenzi; A Costanzo; J Gong; J Y Wang; G Melino
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  8 in total

1.  p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28.

Authors:  Shohreh Amini; Giuseppe Mameli; Luis Del Valle; Anna Skowronska; Krzysztof Reiss; Benjamin B Gelman; Martyn K White; Kamel Khalili; Bassel E Sawaya
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

2.  Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.

Authors:  Hai-Xia Qin; Ke-Jun Nan; Guang Yang; Zhao Jing; Zhi-Ping Ruan; Chun-Li Li; Rui Xu; Hui Guo; Chen-Guang Sui; Yong-Chang Wei
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

Review 3.  Molecular pathogenesis of oligodendroglial tumors.

Authors:  Judith W M Jeuken; Andreas von Deimling; Pieter Wesseling
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

4.  The expression of p73, p21 and MDM2 proteins in gliomas.

Authors:  Makoto Kamiya; Yoichi Nakazato
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

Review 5.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

6.  Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component.

Authors:  Miguel Torres-Martín; Carolina Peña-Granero; Fernando Carceller; Manuel Gutiérrez; Rommel R Burbano; Giovanny R Pinto; Javier S Castresana; Bárbara Melendez; Juan A Rey
Journal:  Mol Cytogenet       Date:  2014-01-06       Impact factor: 2.009

7.  Overexpressed TP73 induces apoptosis in medulloblastoma.

Authors:  Robert C Castellino; Massimiliano De Bortoli; Linda L Lin; Darlene G Skapura; Jessen A Rajan; Adekunle M Adesina; Laszlo Perlaky; Meredith S Irwin; John Y H Kim
Journal:  BMC Cancer       Date:  2007-07-12       Impact factor: 4.430

8.  Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours.

Authors:  Z Dong; Jc-S Pang; M H Ng; W S Poon; L Zhou; H-K Ng
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.